The UNC Eshelman School of Pharmacy offers a variety of fellowships sponsored by the NIH, pharmaceutical industry partners, and traditional academic-funded fellowships. Details regarding these fellowships are included under the following links.
Pharmaceutical Outcomes Research
The Pharmaceutical Outcomes Research fellowship provides support to Ph.D. students in their first and second years in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy. This fellowship provides a competitive stipend, and provides health insurance, paid vacation, and compensation for travel to one professional meeting each year.
Academic Research Fellowships
The Division of Pharmacotherapy and Experimental Therapeutics offers several two-year, industry-sponsored postdoctoral fellowships, as well as academic fellowships. Fellows gain extensive training and experience in developing, writing, managing, and enrolling patients into clinical studies, as well as scientific and grant writing, publications, and presentation skills. In addition, during the first year of their fellowships, fellows will take coursework related to their training program including, but not limited to, biostatistics, pharmacokinetics and pharmacogenomics.
Academic fellows spend the entire duration of their programs at UNC, focusing on clinical, preclinical and in vitro research projects.
- Heart Failure Pharmacotherapy Fellowship
- HIV Pharmacology Fellowship
- Infectious Disease Fellowship
- Oncology Fellowship
DPET Fellow News
Fellows Day June 12, 2017. Congratulations to our outgoing Fellows on the next chapter in their careers! Front row, left to right: Katy Garrett, PharmD, HIV Clinical Pharmacology; Phyllis Lee, PharmD, Global Regulatory Affairs, GSK; Brian Maas, PharmD, Pharmacometrics, QuintilesIMS; Center row, left to right: Richard Tran, PharmD, Drug Development and Clinical Research, PPD; Masooma Razvi, PharmD, Global Regulatory Affairs, GSK; Michael Weber, PharmD, Drug Development and Clinical Research, United Therapeutics; Back row, left to right: Josh Kaullen, PharmD, Pharmacokinetics/Pharmacodynamics, QuintilesIMS; Kathryn Gordon, PharmD, Medical Affairs, United Therapeutics.